0001236031-17-000005.txt : 20170623
0001236031-17-000005.hdr.sgml : 20170623
20170623071337
ACCESSION NUMBER: 0001236031-17-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170622
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 17926331
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-06-22
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Convertible Note
1.69
2017-06-22
4
A
0
147929
250000
A
2017-06-22
2017-12-22
Common Stock
147929
459788
D
Series MM Warrants
1.86
2017-06-22
4
A
0
147929
0.01
A
2017-06-22
2022-06-22
Common Stock
147929
607717
D
Mr. Kersten participated in an offering and purchased a note in the principal amount of $250,000. Shares issuable upon the conversion of the note will be restricted securities unless registered.
Geert Kersten
2017-06-23